SEOM clinical guidelines for anaplastic gliomas (2017)
Clin. transl. oncol. (Print)
; Clin. transl. oncol. (Print);20(1): 16-21, ene. 2018. tab, ilus
Article
in En
| IBECS
| ID: ibc-170463
Responsible library:
ES1.1
Localization: BNCS
ABSTRACT
The SEOM/GEINO clinical guidelines provide recommendations for radiological, and molecular diagnosis, treatment and follow-up of adult patients with anaplastic gliomas (AG). We followed the 2016 WHO classification which specifies the major diagnostic/prognostic and predictive value of IDH1/IDH2 missense mutations and 1p/19q codeletions in AG. The diagnosis of anaplastic oligoastrocytoma is discouraged. Surgery, radiotherapy and chemotherapy with PCV or TMZ are the first-line standard of care for AG with slight modifications according to molecular variables. A multidisciplinary team is highly recommended in the management of these tumors (AU)
RESUMEN
No disponible
Full text:
1
Collection:
06-national
/
ES
Database:
IBECS
Main subject:
Glioma
/
Anaplasia
Type of study:
Guideline
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Clin. transl. oncol. (Print)
Year:
2018
Document type:
Article